Clinical Trials Logo

Clinical Trial Summary

Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical cord blood derived mesenchymal stem cells) in the premature infants with intraventricular hemorrhage (IVH, grade 3-4)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02274428
Study type Interventional
Source Samsung Medical Center
Contact
Status Completed
Phase Phase 1
Start date October 2014
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT03265613 - Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis Phase 1/Phase 2
Not yet recruiting NCT04711200 - LYell SYndrome MEsenchymal Stromal Cells Treatment Phase 1/Phase 2
Recruiting NCT04626583 - Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells Phase 1
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Recruiting NCT04785027 - Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis Phase 1/Phase 2
Recruiting NCT05602116 - ASC - Autism Study Phase 1
Recruiting NCT04918706 - Allogeneic MSC Treatment for Pulmonary Emphysema Phase 2
Completed NCT03392311 - Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis Phase 1/Phase 2
Recruiting NCT05204329 - Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease Early Phase 1
Recruiting NCT05595681 - Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. Phase 1
Not yet recruiting NCT03745417 - Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis Phase 1/Phase 2
Enrolling by invitation NCT03876197 - Mesenchymal Stem Cells for Radiation-induced Xerostomia Phase 1/Phase 2
Terminated NCT04371393 - MSCs in COVID-19 ARDS Phase 3
Completed NCT04275024 - Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients N/A